FGFR2-CCDC6 fusion
|
Cholangiocarcinoma
|
FGFR2-CCDC6 fusion
|
Cholangiocarcinoma
|
infigratinib Sensitive: D – Preclinical
|
infigratinib Sensitive: D – Preclinical
|
FGFR2-CCDC6 fusion
|
Cholangiocarcinoma
|
FGFR2-CCDC6 fusion
|
Cholangiocarcinoma
|
TKI258 Sensitive: D – Preclinical
|
TKI258 Sensitive: D – Preclinical
|
FGFR2-CCDC6 fusion
|
Cholangiocarcinoma
|
FGFR2-CCDC6 fusion
|
Cholangiocarcinoma
|
ponatinib Sensitive: D – Preclinical
|
ponatinib Sensitive: D – Preclinical
|